Offer - Urjas Oil for just ₹ 1 X
Erlokem 150 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Pancreatic Cancer, Non-Small Cell Lung Cancer.
The right dosage of Erlokem 150 Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Erlokem 150 Tablet as well, which are listed below. Usually, these side effects of Erlokem 150 Tablet go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Erlokem 150 Tablet is Moderate for pregnant women and Moderate for women who are breastfeeding. Warnings related to Erlokem 150 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Erlokem 150 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease, Kidney Disease, Lung Disease are examples of such conditions. Other contraindications of Erlokem 150 Tablet have been discussed in the sections ahead.
Additionally, Erlokem 150 Tablet may also adversely react with other medicines. See below for a complete list.
You should also be aware that Erlokem 150 Tablet is not safe while driving, and is not addiction.
Erlokem 150 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Erlokem 150 Tablet safe for pregnant women?
Erlokem may have some side effects during pregnancy. Pregnant women should discontinue the use of Erlokem, and talk to their doctor, if they notice any discomfort.
Is the use of Erlokem 150 Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Erlokem. If you see any side effects, stop taking Erlokem immediately and talk to your doctor. Take Erlokem again, only after your doctor's advice.
What is the effect of Erlokem 150 Tablet on the Kidneys?
Erlokem is completely safe for kidneys.
What is the effect of Erlokem 150 Tablet on the Liver?
Erlokem can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Erlokem 150 Tablet on the Heart?
You can take Erlokem without any fear of damage to the heart.
Erlokem 150 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Erlokem 150 Tablet unless your doctor advises you to do so -
Is this Erlokem 150 Tablet habit forming or addictive?
Forming a habit of Erlokem 150 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Erlokem 150 Tablet, you should not drive or work on any heavy machine, as Erlokem 150 Tablet can make you drowsy.
Is it safe?
Erlokem 150 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Erlokem 150 Tablet is not used to treat mental disorders.
Interaction between Food and Erlokem 150 Tablet
Some foods when eaten with Erlokem 150 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Erlokem 150 Tablet
Information about the interaction of Erlokem 150 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tarceva® (erlotinib)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 870
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 514-516